Standout Papers

Abiraterone acetate for treat... 1982 2026 1996 2011 1.0k
  1. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study (2012)
    Karim Fizazi, Howard I. Scher et al. The Lancet Oncology
  2. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. (1992)
    Timothy J. McDonnell, Patricia Troncoso et al. PubMed
  3. VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer (2017)
    Jianjun Gao, John F. Ward et al. Nature Medicine
  4. The growing teratoma syndrome (1982)
    Christopher J. Logothetis, Melvin L. Samuels et al. Cancer
  5. Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial (2010)
    Bradley Curtis Carthon, Jedd D. Wolchok et al. Clinical Cancer Research

Immediate Impact

16 by Nobel laureates 16 from Science/Nature 76 standout
Sub-graph 1 of 17

Citing Papers

Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
2021 Standout

Works of Christopher J. Logothetis being referenced

VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017 StandoutNobel
CTLA-4 blockade increases IFNγ-producing CD4 + ICOS hi cells to shift the ratio of effector to regulatory T cells in cancer patients
2008
and 2 more

Author Peers

Author Last Decade Papers Cites
Christopher J. Logothetis 9469 7820 6778 448 20.4k
Daniel P. Petrylak 10428 10847 4759 521 22.4k
Atsushi Ochiai 7621 11066 8819 586 24.6k
Giampaolo Tortora 7644 13500 9748 619 23.7k
George Wilding 11923 6748 9776 308 21.9k
Ronald de Wit 13147 10045 4452 371 25.7k
Yoshitaka Fujii 8943 8242 7574 436 19.6k
Walter M. Stadler 13822 9239 11753 466 26.3k
David M. Nanus 8050 4890 6088 326 14.4k
Jeffrey S. Ross 8361 14701 10115 673 27.9k
David S. Hong 6145 10195 9319 810 22.5k

All Works

Loading papers...

Rankless by CCL
2026